Novo Seeds Portfolio Company Galecto Biotech Raises €79 Million in Series C Financing
- Friday, October 26, 2018, 1:00
- Finance
- Add a comment
COPENHAGEN, Denmark, October 26, 2018 /PRNewswire/ — – Novo Seeds invests €12.5 million becoming largest shareholder – Galecto Biotech was first incubated by Novo Seeds and funded through the pre-seed grant programme of the Novo Nordisk Foundation in 2010 Novo Seeds, the early stage…
Source: https://www.prnewswire.com:443/news-releases/novo-seeds-portfolio-company-galecto-biotech-raises-79-million-in-series-c-financing-837676027.html
About the Author
adminasapcorp has written 38951 stories on this site.